Primary prophylaxis best for preventing rheumatic heart disease

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.668, 2012-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias

By Westenbrink B Daan  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 8, 2013-08 ,pp. : 889-903

Informa Healthcare

Access to resources Recommend Favorite

Effect of Left Ventricular Pressure and Volume Overload on -Adrenoceptor Activity in Patients with Rheumatic Heart Valvular Disease

By Dzimiri N.   Moorji A.   Kumar M.   Bakr S.   Kumar N.   Almotrefi A.A.   Halees Z.  

General Pharmacology, Vol. 27, Iss. 3, 1996-04 ,pp. : 539-543

Elsevier

Access to resources Recommend Favorite

Effects of Different Left Ventricular Load Conditions on Myocardial -Adrenoceptor Density in Patients With Rheumatic Heart Valvular Disease

By Dzimiri N.   Moorji A.   Kumar N.   Halees Z.  

General Pharmacology, Vol. 27, Iss. 6, 1996-09 ,pp. : 1019-1023

Elsevier

Access to resources Recommend Favorite

Ethnicity in rheumatic disease

By Kumar Kanta   Klocke Rainer  

Clinical Medicine, Vol. 10, Iss. 4, 2010-08 ,pp. : 370-372

Royal College Of Physicians

Access to resources Recommend Favorite

Preventing group B streptococcal disease: which strategy best?

By  

Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite